Phase 1 Study of Anti-glycation Agent GLY-230 in Healthy Subjects

Completed · Phase 1 · Has a placebo group

Conditions studied: Diabetes

In brief

To test the safety of GLY-230 and to evaluate how long drug stays in blood after taking it by mouth.

Key facts

Study ID

NCT00544921

Run by

Glycadia

People needed

54

Starts

2005-10-01

Expected to finish

2006-10-01

Last updated by the study team

2016-02-10

Who can join

Age: 18 and older, up to 55. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Men age 18-55
• Negative drug screen
• Normal EKG, clinical chemistries, CBC, urinalysis, and
• Give written informed consent

You may not qualify if…

• Active concomitant serious medical or surgical disease,
• Hepatic or renal laboratory values above reference range, ise of other experimental drug within previous 30 days

Where it is running

• Univ FL — Gainesville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.